Sponsor Dossier
Orion Pharma (AUS)
Sponsor Dossier for Orion Pharma (AUS). ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ANKSILON
- Brand: BISALAX
- Brand: BUFOMIX EASYHALER
- Brand: CHEXATE
- Brand: DEXDOR
- Brand: ELDEPRYL
- Brand: FARESTON
- Brand: ORIDOPA
About
Orion Pharma (AUS) is an Australian Private Company with ABN 15654099608, registered in NSW and currently active.
Portfolio
Orion Pharma (AUS) has 11 brands on the ARTG, of which 10 are indexable. The portfolio includes 10 brands with Product Information on file, 4 brands with at least one PBS-listed item, and 2 brands with PBAC outcome records. Notable brands include ANKSILON, BISALAX, BUFOMIX EASYHALER, CHEXATE, DEXDOR, ELDEPRYL, FARESTON, ORIDOPA, SALFLUMIX EASYHALER, SANDRENA, and TAMOSIN.
Therapeutic focus —
Oncology: 4 brands — Neurology: 2 brands — Respiratory: 2 brands — Psychiatry: 1 brand — Gastroenterology: 1 brand — Pain Management: 1 brand
PBS footprint
Four brands in the Orion Pharma (AUS) portfolio have at least one PBS-listed item, with the portfolio most recently touching the PBS schedule on 1 May 2026.
Regulatory activity
The most recent PBAC outcome for Orion Pharma (AUS) occurred on 1 November 2023, with 2 brands holding PBAC outcome records.